Compound Detail
CHEMBL49080
CLENBUTEROL 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL49080 |
| Name | CLENBUTEROL |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | STJMRWALKKWQGH-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
5
Targets
11
Activities
4
Assay Types
0
PK Parameters
20
Publications
7
Known Names
5
Indications
1
Mechanisms
Molecular Properties
277.2
MW (Da)
3.00
ALogP
3
HBA
3
HBD
58.3
PSA (Ų)
0.74
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Beta-2 adrenergic receptor agonist | AGONIST | Beta-2 adrenergic receptor | ✓ | ✓ |
Indications
Lung Diseases, Obstructive Amyotrophic Lateral Sclerosis Bulbo-Spinal Atrophy, X-Linked Glycogen Storage Disease Type II Parkinson Disease
ATC Classification
R03AC14
clenbuterol
Level 1: RESPIRATORY SYSTEM
Level 2: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03CC13
clenbuterol
Level 1: RESPIRATORY SYSTEM
Level 2: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Activity Summary
IC50 4 meas. best 7.39
Ki 4 meas. best 7.55
Kd 2 meas. best 7.8
EC50 1 meas. best 7.89
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Beta-2 adrenergic receptor CHEMBL5414 | EC50 | 7.89 | 7.89 | 13.0 | 1 |
| Beta-2 adrenergic receptor CHEMBL210 | Kd | 7.8 | 7.8 | 15.8 | 1 |
| Beta-2 adrenergic receptor CHEMBL210 | Ki | 7.55 | 6.895 | 28.0 | 2 |
| Beta-2 adrenergic receptor CHEMBL3373 | Kd | 7.44 | 7.44 | 36.0 | 1 |
| Beta-2 adrenergic receptor CHEMBL210 | IC50 | 7.39 | 6.64 | 41.0 | 2 |
| Beta-1 adrenergic receptor CHEMBL213 | Ki | 7.16 | 7.16 | 69.0 | 1 |
| Beta-1 adrenergic receptor CHEMBL213 | IC50 | 6.92 | 6.92 | 120.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | Ki | 5.82 | 5.82 | 1515.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | IC50 | 5.58 | 5.58 | 2652.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.5281/zenodo.13943903 | ADMET | 89 |
| 31158845 | 10.1038/s41586-019-1291-3 | ADMET | 72 |
| 2870189 | 10.1021/jm00154a020 | Beta-2 adrenergic receptor | 4 |
| 19245211 | 10.1021/jm801211c | Beta-2 adrenergic receptor | 4 |
| 12747795 | 10.1021/jm030767c | No relevant target | 4 |
| 2836587 | 10.1021/jm00401a004 | Beta-2 adrenergic receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Androgen receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Cannabinoid receptor 1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-2 adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(1A) dopamine receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 2 |
| 1350309 | 10.1021/jm00088a009 | Beta-3 adrenergic receptor | 2 |
Data from ChEMBL 36 via Core Engine